Cohance Life
₹464.05+4.10 (+0.89%)as of 2026-10-16
- Market Cap
- ₹17,814Cr.
- P/E Ratio
- 165.4
- P/B Ratio
- 4.55
- EPS (TTM)
- ₹2.81
- Day Range
- ₹458.1 – ₹467.35
- Div Yield
- 0%
- ROCE
- 5.81%
- ROE
- 4.89%
52W Low: ₹26752W High: ₹918
Themes:💊 Pharma & CDMO
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 19.0% a year over three years.
- Debt is 0.10× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Cohance_Life — Price
Interval
Style
Failed: 503
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 165.4P/E: 165.4 | P/B: 4.55Growth
GrowingSales CAGR — 3Y: 19% · 1Y: -20%Profitability
Low MarginROCE: 5.81% | ROE: 4.89%Key Metrics
Valuation
Price / Sales 8.32x
Price / FCF 105.4x
Book Value ₹102
Margins & returns
Operating Margin 15%
Net Margin 2.8%
Return on Assets 1.0%